New valproate regulations, informed choice and seizure risk

H Angus-Leppan, R Arkell, L Watkins, D Heaney… - Journal of …, 2024 - Springer
Valproate is the most effective medication for generalised epilepsies, and several specific
epilepsy syndromes. For some people, it will be the only medication to establish seizure …

[HTML][HTML] Reasonable adjustments for people with intellectual disability in acute care: a scoping review of the evidence

M Moloney, T Hennessy, O Doody - BMJ open, 2021 - bmjopen.bmj.com
Objectives People with intellectual disability are vulnerable in terms of health service
provision due to increased comorbidity, higher dependency and cognitive impairment. This …

Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study

JJ Sun, B Perera, W Henley, H Angus-Leppan… - Journal of …, 2022 - Springer
Background A quarter of people with Intellectual Disability (ID) in the UK have epilepsy
compared to 0.6% in the general population and die much younger. Epilepsy is associated …

Epilepsy in adults with neurodevelopmental disability-what every neurologist should know

LV Watkins, C Linehan, C Brandt… - Epileptic …, 2022 - stm.cairn.info
Epilepsy in adults with neurodevelopmental disability - what every neurologist should know |
Cairn.info Cairn.info, Matières à réflexion Cairn.info, Matières à réflexion Aucune suggestion …

Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case–control study

JJ Sun, L Watkins, W Henley, R Laugharne… - Journal of …, 2023 - Springer
Background People with epilepsy (PWE) and people with intellectual disabilities (ID) both
live shorter lives than the general population and both conditions increase the risk of death …

Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England

D Branford, JJ Sun, R Shankar - The British Journal of Psychiatry, 2023 - cambridge.org
Antiseizure medications (ASMs) are the second most widely prescribed psychotropic for
people with intellectual disabilities in England. Multiple psychotropic prescribing is prevalent …

[HTML][HTML] Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability

J Allard, W Henley, A Sellers, E O'Shaughnessy… - Epilepsy & Behavior, 2024 - Elsevier
Abstract Introduction In England, nearly a quarter of people with intellectual disability (PwID)
have epilepsy. Though 70% of PwID have pharmaco-resistant seizures only 10% are …

[HTML][HTML] Tackling increased risks in older adults with intellectual disability and epilepsy: data from a national multicentre cohort study

LV Watkins, W Henley, JJ Sun, B Perera… - Seizure, 2022 - Elsevier
Purpose People with intellectual disabilities (ID) suffer multimorbidity, polypharmacy and
excess mortality at a younger age than general population. Those with ID and epilepsy are …

Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review

S Moon, L Watkins, M O'Dwyer… - Expert Review of …, 2024 - Taylor & Francis
Introduction There is increased focus on the negative impact of the overprescribing of
medication, specifically psychotropic medication, including anti-seizure medications (ASM) …

[HTML][HTML] Improving nocturnal event monitoring in people with intellectual disability in community using an artificial intelligence camera

S Lennard, R Newman, B McLean, C Jory… - Epilepsy & behavior …, 2023 - Elsevier
There is higher prevalence of epilepsy and SUDEP in people with intellectual disability
(PwID) compared to general population. Accurate seizure recording particularly at night can …